X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18226) 18226
Book Review (2555) 2555
Publication (2132) 2132
Newsletter (211) 211
Government Document (210) 210
Book Chapter (204) 204
Conference Proceeding (123) 123
Dissertation (67) 67
Magazine Article (56) 56
Newspaper Article (35) 35
Book / eBook (20) 20
Web Resource (19) 19
Trade Publication Article (9) 9
Data Set (4) 4
Reference (4) 4
Streaming Video (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13872) 13872
humans (13480) 13480
female (10637) 10637
brca1 (7596) 7596
oncology (7416) 7416
breast cancer (7369) 7369
breast neoplasms - genetics (6890) 6890
mutation (5746) 5746
genes, brca1 (4952) 4952
middle aged (4815) 4815
cancer (4756) 4756
adult (4695) 4695
brca1 protein - genetics (3834) 3834
genetic aspects (3809) 3809
ovarian neoplasms - genetics (3420) 3420
ovarian cancer (3284) 3284
genes, brca2 (3227) 3227
ovarian-cancer (3092) 3092
genetic predisposition to disease (3065) 3065
risk factors (3031) 3031
aged (2993) 2993
genetics & heredity (2790) 2790
women (2767) 2767
research (2647) 2647
risk (2475) 2475
breast-cancer (2301) 2301
brca2 (2276) 2276
genes (2095) 2095
brca1 protein (2085) 2085
male (2033) 2033
brca2 protein - genetics (1927) 1927
mutations (1905) 1905
genetic testing (1867) 1867
animals (1866) 1866
health aspects (1865) 1865
biochemistry & molecular biology (1767) 1767
dna repair (1730) 1730
breast neoplasms - pathology (1689) 1689
brca1 protein - metabolism (1626) 1626
cell biology (1600) 1600
genetics (1565) 1565
dna damage (1474) 1474
breast (1461) 1461
tumors (1457) 1457
gene mutations (1456) 1456
brca2 protein (1447) 1447
skin and connective tissue diseases (1419) 1419
analysis (1344) 1344
article (1337) 1337
germ-line mutation (1331) 1331
brca mutations (1284) 1284
prognosis (1244) 1244
brca (1242) 1242
gene (1236) 1236
expression (1190) 1190
proteins (1167) 1167
heterozygote (1122) 1122
mice (1122) 1122
dna (1110) 1110
breast neoplasms - epidemiology (1106) 1106
susceptibility (1083) 1083
care and treatment (1082) 1082
gene expression (1081) 1081
cell line, tumor (1076) 1076
obstetrics & gynecology (1065) 1065
breast neoplasms - diagnosis (1054) 1054
genetic counseling (1054) 1054
medicine & public health (1049) 1049
aged, 80 and over (1040) 1040
homologous recombination (1040) 1040
diagnosis (1039) 1039
chemotherapy (1008) 1008
carriers (977) 977
risk assessment (975) 975
breast neoplasms - metabolism (957) 957
deoxyribonucleic acid--dna (957) 957
pedigree (957) 957
germline mutations (943) 943
families (935) 935
endocrine system diseases (931) 931
survival (926) 926
carcinoma (915) 915
neoplasm proteins - genetics (914) 914
surgery (894) 894
genetic screening (892) 892
genetic research (881) 881
breast neoplasms - prevention & control (879) 879
repair (864) 864
transcription factors - genetics (849) 849
cells (844) 844
oncology, experimental (831) 831
abridged index medicus (812) 812
dna mutational analysis (811) 811
ovarian neoplasms - pathology (786) 786
case-control studies (748) 748
protein (743) 743
gene expression regulation, neoplastic (739) 739
pathology (736) 736
prevalence (736) 736
multidisciplinary sciences (723) 723
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18441) 18441
French (193) 193
German (104) 104
Russian (77) 77
Polish (63) 63
Spanish (51) 51
Czech (48) 48
Dutch (11) 11
Hungarian (11) 11
Chinese (9) 9
Korean (9) 9
Persian (9) 9
Bulgarian (8) 8
Hebrew (8) 8
Japanese (7) 7
Portuguese (7) 7
Croatian (6) 6
Italian (6) 6
Swedish (6) 6
Danish (5) 5
Norwegian (4) 4
Latvian (2) 2
Romanian (2) 2
Serbian (2) 2
Slovak (2) 2
Finnish (1) 1
Icelandic (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLOS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0160174
Triple negative breast cancer is typically an aggressive and difficult to treat subtype. It is often associated with loss of function of the BRCA1 gene, either... 
BRCA1 protein | Breast cancer | Gene expression | Tissues | Blood | Heterozygosity | Loss of heterozygosity | DNA methylation | Epigenetics | Mutation | Methylation | Health risk assessment | Deoxyribonucleic acid--DNA | Tumors | Cancer | CpG islands | Deoxyribonucleic acid | DNA
Journal Article
2014, Genetics and Society, ISBN 9780415824064, xxii, 225
The discovery of the two inherited susceptibility genes BRCA1 and BRCA2 in the mid-1990s created the possibility of predictive genetic testing and led to the... 
BRCA genes | Breast | Genetic aspects | Tumor markers | Cancer | Medicine: General Issues | Health & Medical Anthropology | Anthropology - Soc Sci | New Genetics | Sociology of Science & Technology | Gender Studies | Medicine - Sociology | Bioethics | Genetics - Sociology | Medical Sociology | Sociology & Social Policy | Genetic screening
Book
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 11, pp. e0207399 - e0207399
PARP inhibitors target BRCA mutations and defective homologous recombination repair (HRR) for the treatment of epithelial ovarian cancer (EOC). However, the... 
HOMOLOGOUS RECOMBINATION REPAIR | PEGYLATED LIPOSOMAL DOXORUBICIN | MULTIDISCIPLINARY SCIENCES | 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP | CERVICAL-CANCER | OPEN-LABEL | ANTITUMOR-ACTIVITY | CELL-LINES | RIBONUCLEOTIDE REDUCTASE-ACTIVITY | ENDOTHELIAL GROWTH-FACTOR | TUMOR-CELL | Humans | Mice, SCID | Breast Neoplasms - drug therapy | Piperazines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Phthalazines - pharmacology | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Animals | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Mice, Nude | BRCA1 Protein - metabolism | Cell Line, Tumor | Female | Pyridines - pharmacology | Thiosemicarbazones - pharmacology | Quinazolines - pharmacology | Drug Resistance, Neoplasm - drug effects | Enzyme inhibitors | BRCA mutations | Patient outcomes | Development and progression | Genetic aspects | Drug therapy, Combination | Drug therapy | Health aspects | Methods | Ovarian cancer | Animal models | Severe combined immunodeficiency | Ovarian carcinoma | Xenotransplantation | Homologous recombination | Homology | AKT protein | Kinases | Homologous recombination repair | Ribonucleotide reductase | Xenografts | Protein-tyrosine kinase receptors | Vascular endothelial growth factor | Growth factors | Protein-tyrosine kinase | Tyrosine | Effectiveness | Poly(ADP-ribose) polymerase | Breast cancer | Survival | Inhibitors | Cell lines | Mice | Mutation | Prolongation | Cancer | Tumors | Apoptosis | Reductase | Index Medicus
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 11/2017, Volume 147, Issue 2, pp. 267 - 275
Journal Article
Journal Article
Nature Structural & Molecular Biology, ISSN 1545-9993, 06/2010, Volume 17, Issue 6, pp. 688 - 695
Germ-line mutations in breast cancer 1, early onset (BRCA1) result in predisposition to breast and ovarian cancer. BRCA1-mutated tumors show genomic... 
STEM-CELLS | GENE BRCA1 | DNA-DAMAGE RESPONSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CONDITIONAL MOUSE MODEL | DOUBLE-STRAND BREAKS | OVARIAN-CANCER | CELL BIOLOGY | GENOMIC INSTABILITY | MAMMARY-TUMORS | BIOPHYSICS | TUMOR-SUPPRESSOR | CELL-CYCLE | Embryonic Stem Cells - metabolism | Cell Proliferation | Embryonic Stem Cells - cytology | Humans | Breast Neoplasms - metabolism | Intracellular Signaling Peptides and Proteins - deficiency | Gene Deletion | Genes, BRCA2 | Female | Genes, BRCA1 | Tumor Cells, Cultured | BRCA1 Protein - deficiency | Intracellular Signaling Peptides and Proteins - genetics | DNA-Binding Proteins | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Chromosomal Proteins, Non-Histone | Breast Neoplasms - drug therapy | Mice, Knockout | BRCA1 Protein - genetics | Drug Resistance, Neoplasm - genetics | Animals | Apoptosis Regulatory Proteins | Breast Neoplasms - genetics | Cell Cycle | Breast Neoplasms - pathology | DNA Repair | BRCA2 Protein - deficiency | Mice | Mutagenesis, Insertional | DNA Damage | Mutation | Tumor Suppressor p53-Binding Protein 1 | Drug Resistance, Neoplasm - physiology | BRCA2 Protein - genetics | BRCA mutations | DNA damage | Physiological aspects | Breast cancer | Genetic aspects | Research | Health aspects | DNA repair | Risk factors | Molecular biology | Ovarian cancer | Index Medicus
Journal Article
Journal Article
11/2012
A bilateral salpingo oophorectomy (BSO), removal of the ovaries, is recommended for carriers of BRCA1/2 mutations to reduce cancer risks. However, BSO induces... 
brca | 0633 | estrogen | cognition | oophorectomy
Dissertation
2009, Health and society in video
Pieces of me puts a human face to the accelerating scientific advancements in genetic identification. The science of genetics is expanding faster than cures or... 
BRCA genes | Cancer
Web Resource